img

Global Systemic Antifungals Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Systemic Antifungals Market Insights, Forecast to 2034

Fungal infections are generally divided into superficial infections and deep infections (also known as systemic infections). Superficial fungal infections are often caused by various species of fungi, while deep fungal infections mainly affect internal organs and deep tissues, with a low incidence but a mortality rate of up to 50%. Antifungals are drugs that have the ability to inhibit or kill pathogenic fungi and are used to treat fungal infectious diseases.

Translated with www.DeepL.com/Translator (free version)
Market Analysis and InsightsGlobal Systemic Antifungals Market
Global Systemic Antifungals market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Systemic Antifungals industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Systemic Antifungals market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Systemic Antifungals market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


MSD
Pfizer
Astellas Pharma
Gilead Sciences
Merck
Bayer
Novartis
Liposome Company
Xian-janssen
CR Pharma
Chiatai Tianqing
Haisco Pharmaceutical
Zhuhai Ebang Pharmaceutical
Livzon Group Livzon Pharmaceutical Factory
Honz Pharmaceutical
Medisan
Chengdu Brilliant Pharmaceutical
Segment by Type
Injections
Oral

Segment by Application


Hospital
Clinic
Drugstores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Systemic Antifungals introduction, etc. Systemic Antifungals Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Systemic Antifungals
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Systemic Antifungals Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Injections
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Systemic Antifungals Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drugstores
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Systemic Antifungals Market Perspective (2018-2029)
2.2 Global Systemic Antifungals Growth Trends by Region
2.2.1 Systemic Antifungals Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Systemic Antifungals Historic Market Size by Region (2018-2024)
2.2.3 Systemic Antifungals Forecasted Market Size by Region (2024-2029)
2.3 Systemic Antifungals Market Dynamics
2.3.1 Systemic Antifungals Industry Trends
2.3.2 Systemic Antifungals Market Drivers
2.3.3 Systemic Antifungals Market Challenges
2.3.4 Systemic Antifungals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Systemic Antifungals by Players
3.1.1 Global Systemic Antifungals Revenue by Players (2018-2024)
3.1.2 Global Systemic Antifungals Revenue Market Share by Players (2018-2024)
3.2 Global Systemic Antifungals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Systemic Antifungals, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Systemic Antifungals Market Concentration Ratio
3.4.1 Global Systemic Antifungals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Systemic Antifungals Revenue in 2022
3.5 Global Key Players of Systemic Antifungals Head office and Area Served
3.6 Global Key Players of Systemic Antifungals, Product and Application
3.7 Global Key Players of Systemic Antifungals, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Systemic Antifungals Breakdown Data by Type
4.1 Global Systemic Antifungals Historic Market Size by Type (2018-2024)
4.2 Global Systemic Antifungals Forecasted Market Size by Type (2024-2029)
5 Systemic Antifungals Breakdown Data by Application
5.1 Global Systemic Antifungals Historic Market Size by Application (2018-2024)
5.2 Global Systemic Antifungals Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Systemic Antifungals Market Size (2018-2029)
6.2 North America Systemic Antifungals Market Size by Type
6.2.1 North America Systemic Antifungals Market Size by Type (2018-2024)
6.2.2 North America Systemic Antifungals Market Size by Type (2024-2029)
6.2.3 North America Systemic Antifungals Market Share by Type (2018-2029)
6.3 North America Systemic Antifungals Market Size by Application
6.3.1 North America Systemic Antifungals Market Size by Application (2018-2024)
6.3.2 North America Systemic Antifungals Market Size by Application (2024-2029)
6.3.3 North America Systemic Antifungals Market Share by Application (2018-2029)
6.4 North America Systemic Antifungals Market Size by Country
6.4.1 North America Systemic Antifungals Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Systemic Antifungals Market Size by Country (2018-2024)
6.4.3 North America Systemic Antifungals Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Systemic Antifungals Market Size (2018-2029)
7.2 Europe Systemic Antifungals Market Size by Type
7.2.1 Europe Systemic Antifungals Market Size by Type (2018-2024)
7.2.2 Europe Systemic Antifungals Market Size by Type (2024-2029)
7.2.3 Europe Systemic Antifungals Market Share by Type (2018-2029)
7.3 Europe Systemic Antifungals Market Size by Application
7.3.1 Europe Systemic Antifungals Market Size by Application (2018-2024)
7.3.2 Europe Systemic Antifungals Market Size by Application (2024-2029)
7.3.3 Europe Systemic Antifungals Market Share by Application (2018-2029)
7.4 Europe Systemic Antifungals Market Size by Country
7.4.1 Europe Systemic Antifungals Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Systemic Antifungals Market Size by Country (2018-2024)
7.4.3 Europe Systemic Antifungals Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Systemic Antifungals Market Size (2018-2029)
8.2 China Systemic Antifungals Market Size by Type
8.2.1 China Systemic Antifungals Market Size by Type (2018-2024)
8.2.2 China Systemic Antifungals Market Size by Type (2024-2029)
8.2.3 China Systemic Antifungals Market Share by Type (2018-2029)
8.3 China Systemic Antifungals Market Size by Application
8.3.1 China Systemic Antifungals Market Size by Application (2018-2024)
8.3.2 China Systemic Antifungals Market Size by Application (2024-2029)
8.3.3 China Systemic Antifungals Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Systemic Antifungals Market Size (2018-2029)
9.2 Asia Systemic Antifungals Market Size by Type
9.2.1 Asia Systemic Antifungals Market Size by Type (2018-2024)
9.2.2 Asia Systemic Antifungals Market Size by Type (2024-2029)
9.2.3 Asia Systemic Antifungals Market Share by Type (2018-2029)
9.3 Asia Systemic Antifungals Market Size by Application
9.3.1 Asia Systemic Antifungals Market Size by Application (2018-2024)
9.3.2 Asia Systemic Antifungals Market Size by Application (2024-2029)
9.3.3 Asia Systemic Antifungals Market Share by Application (2018-2029)
9.4 Asia Systemic Antifungals Market Size by Region
9.4.1 Asia Systemic Antifungals Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Systemic Antifungals Market Size by Region (2018-2024)
9.4.3 Asia Systemic Antifungals Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Systemic Antifungals Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Systemic Antifungals Market Size by Type
10.2.1 Middle East, Africa, and Latin America Systemic Antifungals Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Systemic Antifungals Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Systemic Antifungals Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Systemic Antifungals Market Size by Application
10.3.1 Middle East, Africa, and Latin America Systemic Antifungals Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Systemic Antifungals Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Systemic Antifungals Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Systemic Antifungals Market Size by Country
10.4.1 Middle East, Africa, and Latin America Systemic Antifungals Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Systemic Antifungals Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Systemic Antifungals Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 MSD
11.1.1 MSD Company Details
11.1.2 MSD Business Overview
11.1.3 MSD Systemic Antifungals Introduction
11.1.4 MSD Revenue in Systemic Antifungals Business (2018-2024)
11.1.5 MSD Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Systemic Antifungals Introduction
11.2.4 Pfizer Revenue in Systemic Antifungals Business (2018-2024)
11.2.5 Pfizer Recent Developments
11.3 Astellas Pharma
11.3.1 Astellas Pharma Company Details
11.3.2 Astellas Pharma Business Overview
11.3.3 Astellas Pharma Systemic Antifungals Introduction
11.3.4 Astellas Pharma Revenue in Systemic Antifungals Business (2018-2024)
11.3.5 Astellas Pharma Recent Developments
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Details
11.4.2 Gilead Sciences Business Overview
11.4.3 Gilead Sciences Systemic Antifungals Introduction
11.4.4 Gilead Sciences Revenue in Systemic Antifungals Business (2018-2024)
11.4.5 Gilead Sciences Recent Developments
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Systemic Antifungals Introduction
11.5.4 Merck Revenue in Systemic Antifungals Business (2018-2024)
11.5.5 Merck Recent Developments
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Systemic Antifungals Introduction
11.6.4 Bayer Revenue in Systemic Antifungals Business (2018-2024)
11.6.5 Bayer Recent Developments
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Systemic Antifungals Introduction
11.7.4 Novartis Revenue in Systemic Antifungals Business (2018-2024)
11.7.5 Novartis Recent Developments
11.8 Liposome Company
11.8.1 Liposome Company Company Details
11.8.2 Liposome Company Business Overview
11.8.3 Liposome Company Systemic Antifungals Introduction
11.8.4 Liposome Company Revenue in Systemic Antifungals Business (2018-2024)
11.8.5 Liposome Company Recent Developments
11.9 Xian-janssen
11.9.1 Xian-janssen Company Details
11.9.2 Xian-janssen Business Overview
11.9.3 Xian-janssen Systemic Antifungals Introduction
11.9.4 Xian-janssen Revenue in Systemic Antifungals Business (2018-2024)
11.9.5 Xian-janssen Recent Developments
11.10 CR Pharma
11.10.1 CR Pharma Company Details
11.10.2 CR Pharma Business Overview
11.10.3 CR Pharma Systemic Antifungals Introduction
11.10.4 CR Pharma Revenue in Systemic Antifungals Business (2018-2024)
11.10.5 CR Pharma Recent Developments
11.11 Chiatai Tianqing
11.11.1 Chiatai Tianqing Company Details
11.11.2 Chiatai Tianqing Business Overview
11.11.3 Chiatai Tianqing Systemic Antifungals Introduction
11.11.4 Chiatai Tianqing Revenue in Systemic Antifungals Business (2018-2024)
11.11.5 Chiatai Tianqing Recent Developments
11.12 Haisco Pharmaceutical
11.12.1 Haisco Pharmaceutical Company Details
11.12.2 Haisco Pharmaceutical Business Overview
11.12.3 Haisco Pharmaceutical Systemic Antifungals Introduction
11.12.4 Haisco Pharmaceutical Revenue in Systemic Antifungals Business (2018-2024)
11.12.5 Haisco Pharmaceutical Recent Developments
11.13 Zhuhai Ebang Pharmaceutical
11.13.1 Zhuhai Ebang Pharmaceutical Company Details
11.13.2 Zhuhai Ebang Pharmaceutical Business Overview
11.13.3 Zhuhai Ebang Pharmaceutical Systemic Antifungals Introduction
11.13.4 Zhuhai Ebang Pharmaceutical Revenue in Systemic Antifungals Business (2018-2024)
11.13.5 Zhuhai Ebang Pharmaceutical Recent Developments
11.14 Livzon Group Livzon Pharmaceutical Factory
11.14.1 Livzon Group Livzon Pharmaceutical Factory Company Details
11.14.2 Livzon Group Livzon Pharmaceutical Factory Business Overview
11.14.3 Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Introduction
11.14.4 Livzon Group Livzon Pharmaceutical Factory Revenue in Systemic Antifungals Business (2018-2024)
11.14.5 Livzon Group Livzon Pharmaceutical Factory Recent Developments
11.15 Honz Pharmaceutical
11.15.1 Honz Pharmaceutical Company Details
11.15.2 Honz Pharmaceutical Business Overview
11.15.3 Honz Pharmaceutical Systemic Antifungals Introduction
11.15.4 Honz Pharmaceutical Revenue in Systemic Antifungals Business (2018-2024)
11.15.5 Honz Pharmaceutical Recent Developments
11.16 Medisan
11.16.1 Medisan Company Details
11.16.2 Medisan Business Overview
11.16.3 Medisan Systemic Antifungals Introduction
11.16.4 Medisan Revenue in Systemic Antifungals Business (2018-2024)
11.16.5 Medisan Recent Developments
11.17 Chengdu Brilliant Pharmaceutical
11.17.1 Chengdu Brilliant Pharmaceutical Company Details
11.17.2 Chengdu Brilliant Pharmaceutical Business Overview
11.17.3 Chengdu Brilliant Pharmaceutical Systemic Antifungals Introduction
11.17.4 Chengdu Brilliant Pharmaceutical Revenue in Systemic Antifungals Business (2018-2024)
11.17.5 Chengdu Brilliant Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Systemic Antifungals Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Injections
Table 3. Key Players of Oral
Table 4. Global Systemic Antifungals Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Systemic Antifungals Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Systemic Antifungals Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Systemic Antifungals Market Share by Region (2018-2024)
Table 8. Global Systemic Antifungals Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Systemic Antifungals Market Share by Region (2024-2029)
Table 10. Systemic Antifungals Market Trends
Table 11. Systemic Antifungals Market Drivers
Table 12. Systemic Antifungals Market Challenges
Table 13. Systemic Antifungals Market Restraints
Table 14. Global Systemic Antifungals Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Systemic Antifungals Revenue Share by Players (2018-2024)
Table 16. Global Top Systemic Antifungals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Antifungals as of 2022)
Table 17. Global Systemic Antifungals Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Systemic Antifungals Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Systemic Antifungals, Headquarters and Area Served
Table 20. Global Key Players of Systemic Antifungals, Product and Application
Table 21. Global Key Players of Systemic Antifungals, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Systemic Antifungals Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Systemic Antifungals Revenue Market Share by Type (2018-2024)
Table 25. Global Systemic Antifungals Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Systemic Antifungals Revenue Market Share by Type (2024-2029)
Table 27. Global Systemic Antifungals Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Systemic Antifungals Revenue Share by Application (2018-2024)
Table 29. Global Systemic Antifungals Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Systemic Antifungals Revenue Share by Application (2024-2029)
Table 31. North America Systemic Antifungals Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Systemic Antifungals Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Systemic Antifungals Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Systemic Antifungals Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Systemic Antifungals Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Systemic Antifungals Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Systemic Antifungals Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Systemic Antifungals Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Systemic Antifungals Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Systemic Antifungals Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Systemic Antifungals Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Systemic Antifungals Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Systemic Antifungals Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Systemic Antifungals Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Systemic Antifungals Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Systemic Antifungals Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Systemic Antifungals Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Systemic Antifungals Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Systemic Antifungals Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Systemic Antifungals Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Systemic Antifungals Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Systemic Antifungals Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Systemic Antifungals Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Systemic Antifungals Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Systemic Antifungals Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Systemic Antifungals Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Systemic Antifungals Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Systemic Antifungals Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Systemic Antifungals Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Systemic Antifungals Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Systemic Antifungals Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Systemic Antifungals Market Size by Country (2024-2029) & (US$ Million)
Table 63. MSD Company Details
Table 64. MSD Business Overview
Table 65. MSD Systemic Antifungals Product
Table 66. MSD Revenue in Systemic Antifungals Business (2018-2024) & (US$ Million)
Table 67. MSD Recent Developments
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Systemic Antifungals Product
Table 71. Pfizer Revenue in Systemic Antifungals Business (2018-2024) & (US$ Million)
Table 72. Pfizer Recent Developments
Table 73. Astellas Pharma Company Details
Table 74. Astellas Pharma Business Overview
Table 75. Astellas Pharma Systemic Antifungals Product
Table 76. Astellas Pharma Revenue in Systemic Antifungals Business (2018-2024) & (US$ Million)
Table 77. Astellas Pharma Recent Developments
Table 78. Gilead Sciences Company Details
Table 79. Gilead Sciences Business Overview
Table 80. Gilead Sciences Systemic Antifungals Product
Table 81. Gilead Sciences Revenue in Systemic Antifungals Business (2018-2024) & (US$ Million)
Table 82. Gilead Sciences Recent Developments
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Systemic Antifungals Product
Table 86. Merck Revenue in Systemic Antifungals Business (2018-2024) & (US$ Million)
Table 87. Merck Recent Developments
Table 88. Bayer Company Details
Table 89. Bayer Business Overview
Table 90. Bayer Systemic Antifungals Product
Table 91. Bayer Revenue in Systemic Antifungals Business (2018-2024) & (US$ Million)
Table 92. Bayer Recent Developments
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis Systemic Antifungals Product
Table 96. Novartis Revenue in Systemic Antifungals Business (2018-2024) & (US$ Million)
Table 97. Novartis Recent Developments
Table 98. Liposome Company Company Details
Table 99. Liposome Company Business Overview
Table 100. Liposome Company Systemic Antifungals Product
Table 101. Liposome Company Revenue in Systemic Antifungals Business (2018-2024) & (US$ Million)
Table 102. Liposome Company Recent Developments
Table 103. Xian-janssen Company Details
Table 104. Xian-janssen Business Overview
Table 105. Xian-janssen Systemic Antifungals Product
Table 106. Xian-janssen Revenue in Systemic Antifungals Business (2018-2024) & (US$ Million)
Table 107. Xian-janssen Recent Developments
Table 108. CR Pharma Company Details
Table 109. CR Pharma Business Overview
Table 110. CR Pharma Systemic Antifungals Product
Table 111. CR Pharma Revenue in Systemic Antifungals Business (2018-2024) & (US$ Million)
Table 112. CR Pharma Recent Developments
Table 113. Chiatai Tianqing Company Details
Table 114. Chiatai Tianqing Business Overview
Table 115. Chiatai Tianqing Systemic Antifungals Product
Table 116. Chiatai Tianqing Revenue in Systemic Antifungals Business (2018-2024) & (US$ Million)
Table 117. Chiatai Tianqing Recent Developments
Table 118. Haisco Pharmaceutical Company Details
Table 119. Haisco Pharmaceutical Business Overview
Table 120. Haisco Pharmaceutical Systemic Antifungals Product
Table 121. Haisco Pharmaceutical Revenue in Systemic Antifungals Business (2018-2024) & (US$ Million)
Table 122. Haisco Pharmaceutical Recent Developments
Table 123. Zhuhai Ebang Pharmaceutical Company Details
Table 124. Zhuhai Ebang Pharmaceutical Business Overview
Table 125. Zhuhai Ebang Pharmaceutical Systemic Antifungals Product
Table 126. Zhuhai Ebang Pharmaceutical Revenue in Systemic Antifungals Business (2018-2024) & (US$ Million)
Table 127. Zhuhai Ebang Pharmaceutical Recent Developments
Table 128. Livzon Group Livzon Pharmaceutical Factory Company Details
Table 129. Livzon Group Livzon Pharmaceutical Factory Business Overview
Table 130. Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Product
Table 131. Livzon Group Livzon Pharmaceutical Factory Revenue in Systemic Antifungals Business (2018-2024) & (US$ Million)
Table 132. Livzon Group Livzon Pharmaceutical Factory Recent Developments
Table 133. Honz Pharmaceutical Company Details
Table 134. Honz Pharmaceutical Business Overview
Table 135. Honz Pharmaceutical Systemic Antifungals Product
Table 136. Honz Pharmaceutical Revenue in Systemic Antifungals Business (2018-2024) & (US$ Million)
Table 137. Honz Pharmaceutical Recent Developments
Table 138. Medisan Company Details
Table 139. Medisan Business Overview
Table 140. Medisan Systemic Antifungals Product
Table 141. Medisan Revenue in Systemic Antifungals Business (2018-2024) & (US$ Million)
Table 142. Medisan Recent Developments
Table 143. Chengdu Brilliant Pharmaceutical Company Details
Table 144. Chengdu Brilliant Pharmaceutical Business Overview
Table 145. Chengdu Brilliant Pharmaceutical Systemic Antifungals Product
Table 146. Chengdu Brilliant Pharmaceutical Revenue in Systemic Antifungals Business (2018-2024) & (US$ Million)
Table 147. Chengdu Brilliant Pharmaceutical Recent Developments
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Systemic Antifungals Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Systemic Antifungals Market Share by Type: 2022 VS 2029
Figure 3. Injections Features
Figure 4. Oral Features
Figure 5. Global Systemic Antifungals Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Systemic Antifungals Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Drugstores Case Studies
Figure 10. Others Case Studies
Figure 11. Systemic Antifungals Report Years Considered
Figure 12. Global Systemic Antifungals Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Systemic Antifungals Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Systemic Antifungals Market Share by Region: 2022 VS 2029
Figure 15. Global Systemic Antifungals Market Share by Players in 2022
Figure 16. Global Top Systemic Antifungals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Antifungals as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Systemic Antifungals Revenue in 2022
Figure 18. North America Systemic Antifungals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Systemic Antifungals Market Share by Type (2018-2029)
Figure 20. North America Systemic Antifungals Market Share by Application (2018-2029)
Figure 21. North America Systemic Antifungals Market Share by Country (2018-2029)
Figure 22. United States Systemic Antifungals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Systemic Antifungals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Systemic Antifungals Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Systemic Antifungals Market Share by Type (2018-2029)
Figure 26. Europe Systemic Antifungals Market Share by Application (2018-2029)
Figure 27. Europe Systemic Antifungals Market Share by Country (2018-2029)
Figure 28. Germany Systemic Antifungals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Systemic Antifungals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Systemic Antifungals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Systemic Antifungals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Systemic Antifungals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Systemic Antifungals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Systemic Antifungals Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Systemic Antifungals Market Share by Type (2018-2029)
Figure 36. China Systemic Antifungals Market Share by Application (2018-2029)
Figure 37. Asia Systemic Antifungals Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Systemic Antifungals Market Share by Type (2018-2029)
Figure 39. Asia Systemic Antifungals Market Share by Application (2018-2029)
Figure 40. Asia Systemic Antifungals Market Share by Region (2018-2029)
Figure 41. Japan Systemic Antifungals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Systemic Antifungals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Systemic Antifungals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Systemic Antifungals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Systemic Antifungals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Systemic Antifungals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Systemic Antifungals Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Systemic Antifungals Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Systemic Antifungals Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Systemic Antifungals Market Share by Country (2018-2029)
Figure 51. Brazil Systemic Antifungals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Systemic Antifungals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Systemic Antifungals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Systemic Antifungals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Systemic Antifungals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Systemic Antifungals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. MSD Revenue Growth Rate in Systemic Antifungals Business (2018-2024)
Figure 58. Pfizer Revenue Growth Rate in Systemic Antifungals Business (2018-2024)
Figure 59. Astellas Pharma Revenue Growth Rate in Systemic Antifungals Business (2018-2024)
Figure 60. Gilead Sciences Revenue Growth Rate in Systemic Antifungals Business (2018-2024)
Figure 61. Merck Revenue Growth Rate in Systemic Antifungals Business (2018-2024)
Figure 62. Bayer Revenue Growth Rate in Systemic Antifungals Business (2018-2024)
Figure 63. Novartis Revenue Growth Rate in Systemic Antifungals Business (2018-2024)
Figure 64. Liposome Company Revenue Growth Rate in Systemic Antifungals Business (2018-2024)
Figure 65. Xian-janssen Revenue Growth Rate in Systemic Antifungals Business (2018-2024)
Figure 66. CR Pharma Revenue Growth Rate in Systemic Antifungals Business (2018-2024)
Figure 67. Chiatai Tianqing Revenue Growth Rate in Systemic Antifungals Business (2018-2024)
Figure 68. Haisco Pharmaceutical Revenue Growth Rate in Systemic Antifungals Business (2018-2024)
Figure 69. Zhuhai Ebang Pharmaceutical Revenue Growth Rate in Systemic Antifungals Business (2018-2024)
Figure 70. Livzon Group Livzon Pharmaceutical Factory Revenue Growth Rate in Systemic Antifungals Business (2018-2024)
Figure 71. Honz Pharmaceutical Revenue Growth Rate in Systemic Antifungals Business (2018-2024)
Figure 72. Medisan Revenue Growth Rate in Systemic Antifungals Business (2018-2024)
Figure 73. Chengdu Brilliant Pharmaceutical Revenue Growth Rate in Systemic Antifungals Business (2018-2024)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed